Applying Lucentis for the treatment of retinopathy of prematurity by S. V. Lesovoy, O. A. Boginskaya

“…Purpose: to evaluate the efficacy of Lucentis for the treatment of retinopathy of prematurity (ROP). …”
Get full text

Looking beyond Lucentis on the management of macular degeneration. by Fletcher, E, Chong, N

Efficacy of adjunctive intravitreous injection with Lucentis for neovascular glaucoma by Rui-Dong Gu, Ruo-Xi Li

Subjects: “…Lucentis…”
Get full text

Treatment of Radiation Retinopathy with Intravitreal Injection of Ranibizumab (Lucentis®) by Horowitz SA, Damasceno NP, Damasceno EF

“…The patient underwent intravitreal injection (0.05 mL) of ranibizumab (Lucentis®) monthly in both eyes and follow-up through visual acuity and OCT examination. …”
Get full text

On the efficiency of treatment of wet age-related macular degeneration with Lucentis by E. M. Kasimov, A. M. Shakhmaliyeva, B. H. Gadzhiyeva

“…The paper studies the efficiency of ranibizumab (Lucentis, Novartis Pharma), a VEGF blocker inhibiting angiogenesis, in patients with wet age macular degeneration (AMD) at different stages of the pathological process. …”
Get full text

Intravitreal lucentis combined laser photocoagulation treatment on macular edema by Tan-Wei Wei, Chen Qiao, Ming Yan

Subjects: “…intravitreal lucentis…”
Get full text

Formulation and in-vitro release studies of Ranibizumab (Lucentis) loaded liposomes by Ang, Jin Yan

“…Physical Characterization of Lucentis was carried out with the effect of incubation of Lucentis under temperature and Triton X-100. …”
Get full text

Effects of ranibizumab (Lucentis®) and bevacizumab (Avastin®) on human corneal endothelial cells by Patrick R. Merz, Nina Röckel, Seda Ballikaya, Gerd U. Auffarth, Ingo Schmack

“…The aim of the study was to investigate potential cytotoxic effects of two anti-VEGF agents, ranibizumab (Lucentis®) and bevacizumab (Avastin®) on the human corneal endothelium. …”
Get full text

Intravitreous injection of Lucentis combined with argon laser photocoagulation for treatment of retinal macroaneurysm by Pu Wang, Yi-Qiao Xing, Chang-Zheng Chen, Zhen Chen, Zhi-Min Qian

Subjects: Get full text

Efficacy of intravitreal Lucentis injection on major and macular branch retinal vein occlusion by Jing Wang, Ying Li, Shu-Fen Fang, Hong Wang

Subjects: “…Lucentis…”
Get full text

Beovu, but not Lucentis impairs the function of the barrier formed by retinal endothelial cells in vitro by Heidrun L. Deissler, Catharina Busch, Armin Wolf, Matus Rehak

“…Interestingly, polysorbate-80—component of Beovu—but not polysorbate-20—in Lucentis—slightly, but significantly lowered the cell index, also associated with reduced claudin-1 expression. …”
Get full text

A case of subacute cutaneous lupus erythematosus as a result of ranibizumab (Lucentis) treatment by Marko Andric, Shreya Dixit, Dana Robaei, Rosemary Watchorn, Nitin Verma

“…Following a single intraocular injection of Lucentis (ranibizumab), she developed a subacute cutaneous lupus erythematosus which, with treatment, took nearly 12 months to resolve. …”
Get full text

INTRAVITREAL INTRODUCTION OF LUCENTIS AND TRANS-SCLERAL CYCLOPHOTOCOAGULATION IN THE TREATMENT OF NEOVASCULAR GLAUCOMA IN DIABETES MELLITUS by V. P. Fokin, S. V. Balalin, T. G. Yefremova, V. N. Potapova

“…During the year period, the second stage (intravitreal introduction of Lucentis) was performed in all patients. As a result, IOP was reduced to 17.5 ± 0.09 mmHg. …”
Get full text

Comparison of Aflibercept (Eylea®) with Ranibizumab (Lucentis®) in treatment of diabetic macular edema by Optical Coherence Tomography by Hossam El din Khalil, Abdel Rahman Ahmed, Hassan Mahfouz Eliwa

“…Objective: To compare the effect of Aflibercept (Eylea®) with Ranibizumab (Lucentis®) in treatment of diabetic macular edema by OCT. …”
Get full text

Comparative study of inhibition effects of Avastin and Lucentis on human umbilical vein endothelial cell proliferation and migration by Xin Jin, Bing Chen, Tie-Cheng Liu, Mao-Nian Zhang

Subjects: Get full text

Study of intravitreal injection of bevacizumab or lucentis before Ahmed glaucoma valve implantation on the treatment of neovascular glaucoma by Yong Liu, Gong-Xun Ping

Subjects: Get full text

Macular functional changes in patients with neovascular age-related macular degeneration receiving ranibizumab therapy (lucentis) by Scorcia G, Randazzo G, Campagna F, Scalzo G C

Efficacy of intravitreal injection of Lucentis in the treatment of diffuse diabetic macular edema associated with pan-retinal photocoagulation in proliferative diabetic retinopathy by L. N. Boriskina, M. Y. Guro, V. N. Potapova, I. A. Melichova, V. R. Polyakova

Subjects: “…intravitreal injection of lucentis…”
Get full text

Comparison between the Effect of Aflibercept (Eylea) and Ranibizumab (Lucentis) on Intraocular Pressure after 3rd Injection in Treatment of Diabetic Macular Edema by Hossam El Deen Khalil, Ahmed Gouda, Ibrahim Abd Allah

Subjects: Get full text

Intravitreal injection of ranibizumab (Lucentis) versus pan-retinal photocoagulation as a preoperative adjuvant before vitrectomy in management of proliferative diabetic retinopathy by Mohammed S Ahmed

“…Aim This study was conducted to study the effect of intravitreal injection of ranibizumab 10 mg/ml (Lucentis) versus PRP as an adjuvant before vitrectomy in the management of PDR. …”
Get full text